		Quarter ended						Three quarters ended
		September 28, 2024			September 30, 2023			September 28, 2024			September 30, 2023
Numerator
Loss from continuing operations	$	(5,498	)	$	(5,680	)	$	(5,442	)	$	(20,158	)
Less: dividends and accretion on preferred stock		(137	)		(426	)		(401	)		(1,552	)
Loss from continuing operations attributable to common shareholders		(5,635	)		(6,106	)		(5,843	)		(21,710	)
Net loss from discontinued operations		-			(140,143	)		(2,314	)		(143,126	)
Loss attributable to common shareholders	$	(5,635	)	$	(146,249	)	$	(8,157	)	$	(164,836	)

Denominator
Basic weighted-average number of shares outstanding		116,841			115,616			116,504			113,700
Dilutive effect of the following:
Stock options, restricted stock units and performance share units⁽¹⁾		-			-			-			-
Series B-1 Preferred Stock⁽²⁾		-			-			-			-
Diluted weighted-average number of shares outstanding		116,841			115,616			116,504			113,700

Basic and Diluted Loss Per Share
Loss from continuing operations attributable to common shareholders	$	(0.05	)	$	(0.05	)	$	(0.05	)	$	(0.19	)
Net loss from discontinued operations		-			(1.21	)		(0.02	)		(1.26	)
Loss attributable to common shareholders	$	(0.05	)	$	(1.26	)	$	(0.07	)	$	(1.45	)

(1) For the quarter and three quarters ended September 28, 2024, 656,831 (September 30, 2023 - 535,747) and 869,143 (September 30, 2023 - 1,454,775) potential common shares, respectively, were excluded from the calculation of diluted loss per share due to their effect of reducing the loss per share from continuing operations. Dilutive potential common shares consist of stock options, RSUs, and certain contingently issuable PSUs. For the quarter and three quarters ended September 28, 2024, stock options and RSUs to purchase or receive 2,550,555 (September 30, 2023 - 3,181,357) and 2,694,555 (September 30, 2023 - 2,779,778) potential common shares, respectively, were anti-dilutive because the assumed proceeds exceeded the average market price of the Common Shares for the respective periods.

(2) For the quarters and three quarters ended September 28, 2024 and September 30, 2023, it was more dilutive to the loss per share from continuing operations to assume the Series B-1 Preferred Stock was not converted into Common Shares and, therefore, the numerator of the diluted loss per share calculation was not adjusted to add back the dividends and accretion on the Series B-1 Preferred Stock and the denominator was not adjusted to include the 6,089,333 Common Shares issuable on an if-converted basis as at September 28, 2024 and September 30, 2023.